This study investigates the role of SLC7A11, a ferroptosis‐related gene, in NSCLC progression and the potential of engineered bacterial extracellular vesicles (BEVs) expressing SLC7A11‐targeting siRNA as a therapeutic strategy. Here, SLC7A11 is linked to non-small cell lung carcinoma.